PHIO PHARMACEUTICALS CORP. Payments to Acquire Short-term Investments
PHIO PHARMACEUTICALS CORP. (PHIO) reported Payments to Acquire Short-term Investments of $2.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2018-03-26
- PHIO PHARMACEUTICALS CORP. payments to acquire short-term investments for the quarter ending 2016-12-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. payments to acquire short-term investments for the quarter ending 2016-09-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. payments to acquire short-term investments for the quarter ending 2015-12-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. payments to acquire short-term investments for the quarter ending 2015-09-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. payments to acquire short-term investments for fiscal 2016 was $2.00M, a 75.00% decline from fiscal 2015.
- PHIO PHARMACEUTICALS CORP. payments to acquire short-term investments for fiscal 2015 was $8.00M, a 60.00% increase from fiscal 2014.
- PHIO PHARMACEUTICALS CORP. payments to acquire short-term investments for fiscal 2014 was $5.00M, a 44.44% decline from fiscal 2013.
- PHIO PHARMACEUTICALS CORP. payments to acquire short-term investments for fiscal 2013 was $9.00M.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month | Payments to Acquire Short-term Investments 111 month | Payments to Acquire Short-term Investments 114 month | Payments to Acquire Short-term Investments 117 month |
|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-26 | $0.00 derived: sum of 2 quarters · filed 2018-03-26 | $2.00M 10-K · filed 2018-03-26 | ||||
| 2016-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-03-26 | $2.00M 10-Q/A · filed 2018-03-26 | |||||
| 2016-06-30 | $2.00M 10-Q/A · filed 2018-03-26 | ||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $0.00 derived: sum of 2 quarters · filed 2017-03-30 | $8.00M 10-K · filed 2017-03-30 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $8.00M 10-Q · filed 2016-11-10 | |||||
| 2015-06-30 | $8.00M 10-Q · filed 2016-08-11 | ||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $5.00M 10-K · filed 2016-03-30 | |||||
| 2014-09-30 | $5.00M 10-Q · filed 2015-11-12 | ||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $0.00 derived: sum of 2 quarters · filed 2015-03-30 | $9.00M 10-K · filed 2015-03-30 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $9.00M 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | $9.00M 10-Q · filed 2014-08-14 | ||||||
| 2012-09-30 | $0.00 derived: 10-Q 117 month − 10-Q 114 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $37.53M 10-Q · filed 2012-11-13 | ||||
| 2012-06-30 | $0.00 derived: 10-Q 114 month − 10-Q 111 month · filed 2012-08-14 | $37.53M 10-Q · filed 2012-08-14 | |||||
| 2012-03-31 | $37.53M 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |